HPS Pharmacies wish to give notice that Pfizer is experiencing a supply interruption for ephedrine sulfate as follows:

DBL™ Ephedrine SulfateEphedrine Sulfate 30mg/1mLARTG 16325 

This is a long-term supply interruption. However, warehouses in some states may still have limited quantities of DBL™ Ephedrine Sulfate injection available.

If alternative presentations of ephedrine are considered, it should be noted that the ephedrine content may differ as shown in the following dose equivalencies:

  • Ephedrine hydrochloride 30 mg/mL contains ephedrine 25 mg/mL
  • Ephedrine sulfate 30 mg/mL contains ephedrine 23.1 mg/mL

Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact Pfizer on 1800 629 921 or your pharmacist at HPS Pharmacies.


1.     Rossi S (editor). Australian Medicines Handbook. Adelaide: AMH; 2022

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates